Search
Cancer Types
Symptoms of Esophageal Cancer
… of Esophageal Cancer Esophageal Cancer Q&A with Dr. Fountzilas Like many cancer types, esophageal cancer does not … opinion Risk factors … Esophageal Cancer Q&A with Dr. Fountzilas Like many cancer types, esophageal cancer does not …
Clinical Trial
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma
… Metastatic Pancreatic Ductal Adenocarcinoma III Fountzilas, Christos The purpose of this study is to compare …
Clinical Trial
RASolute 302: A Phase 3 Multicenter, Open-label, Randomized Study of RMC-6236 versus Investigator's Choice of Standard of Care Therapy in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
… Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) III Fountzilas, Christos The purpose of this study is to evaluate …
Clinical Trial
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor…
… (FGFR)-altered, Chemotherapy- and FGFR Inhibitor… III Fountzilas, Christos This study is a Phase III, Randomized, …
Clinical Trial
A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of onCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors (OASIS)
… Adults with Advanced or Metastatic Solid Tumors (OASIS) I Fountzilas, Christos This is an open-label, dose escalation …
Clinical Trial
HERTHENA-PanTumor01 (U31402-277): A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Subjects with Locally Advanced or Metastatic Solid Tumors
… with Locally Advanced or Metastatic Solid Tumors II Fountzilas, Christos This is a proof-of-concept study …
Clinical Trial
A Phase 1, Open-Label, Dose Escalation and Expansion, Multicenter Study of Claudin 18.2 Targeted Chimeric Antigen Receptor T-cells in Subjects with Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or…
… Gastroesophageal Junction (GEJ), Esophageal, or… I Fountzilas, Christos This is a Phase 1, Open-Label, Dose …
Clinical Trial
A Phase I Study of Trifluridine/ Tipiracil plus the Poly (ADP) Ribose Polymerase Inhibitor Talazoparib in Advanced Cancers
… Polymerase Inhibitor Talazoparib in Advanced Cancers I Fountzilas, Christos This phase I trial investigates the side …
Clinical Trial
A Phase 1b/2, Dose-escalation, Randomized, Multi-Center Study of Maintenance Ivaltinostat plus Capecitabine or Capecitabine Monotherapy in Patients with Metastatic Pancreatic Adenocarcinoma whose Disease has not Progressed on First Line FOLFIRINOX…
… Disease has not Progressed on First Line FOLFIRINOX… I Fountzilas, Christos This study is a Phase 1b/2, …
Clinical Trial
A Phase 2 Clinical Trial of Nalirifox as Neoadjuvant Treatment for Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
… Borderline Resectable Pancreatic Ductal Adenocarcinoma II Fountzilas, Christos This phase II trial tests how well …